All Pharma News
BIMZELX Phase 3 Showed Improvements in Skin Pain and Draining Tunnel Count

BIMZELX Phase 3 Showed Improvements in Skin Pain and Draining Tunnel Count
PR NEWSWIRE
08 Mar 2024
Share Share
After busy 2023, UCB expects approval spree to keep rolling

After busy 2023, UCB expects approval spree to keep rolling
FIERCE PHARMA
29 Feb 2024
Share Share
UCB on Growth Path for a Decade Plus

UCB on Growth Path for a Decade Plus
PR NEWSWIRE
28 Feb 2024
Share Share
FDA Issues Form 483 to UCB Farchim SA

FDA Issues Form 483 to UCB Farchim SA

FDA
24 Oct 2023
Share Share
UCB presents late-breaking posters at Child Neurology Society Meeting

UCB presents late-breaking posters at Child Neurology Society Meeting
PR NEWSWIRE
04 Oct 2023
Share Share
FDA reviews UCB psoriasis drug after manufacturing inspection

FDA reviews UCB psoriasis drug after manufacturing inspection
Zoey Becker FIERCE PHARMA
20 Sep 2023
Share Share
Lundbeck hires UCB neurology exec as new CEO

Lundbeck hires UCB neurology exec as new CEO
Angus Liu FIERCE PHARMA
27 Jun 2023
Share Share
Ariceum and UCB to seek therapies for immune-related diseases and cancer

Ariceum and UCB to seek therapies for immune-related diseases and cancer
PHARMACEUTICAL TECHNOLOGY
11 May 2023
Share Share
UCB touts new data for bimekizumab in hidradenitis suppurativa

UCB touts new data for bimekizumab in hidradenitis suppurativa
FIERCE PHARMA
20 Mar 2023
Share Share
UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis

UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis
PHARMATIMES
02 Aug 2021
Share Share